Sahlgrenska University Hospital — Gothenburg

Public research footprint of Sahlgrenska University Hospital, compiled from the ClinicalTrials.gov public registry.

819

Registered studies

286

Active

181

Recruiting now

404

Completed

Stopped or withdrawn

Most-studied conditions

CIDP - Chronic Inflammatory Demyelinating Polyneuropathy · Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Non-Small Cell Lung Cancer

Recently updated registry entries

NCT06534983 — A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus… (Active Not Recruiting)
NCT02102165 — AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer. (Recruiting)
NCT05006716 — A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Sahlgrenska University Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.